In addition to increased risk for death, hospital and ICU lengths of stay are longer<\/p>\n<\/h3>\n
<\/b><\/p>\n
<\/b><\/p>\n
FRIDAY, April 16, 2021 (HealthDay News) — COVID-19 ups the risk for death with hemorrhagic stroke by more than twofold, according to a study published online April 14 in PLOS ONE<\/em>.<\/p>\n Vijay M. Ravindra, M.D., from the Naval Medical Center San Diego, and colleagues retrospectively analyzed data from the Vizient Clinical Data Base to compare patients with COVID-19 admitted April 1 to Oct. 31, 2020, with intracerebral hemorrhage (ICH) or subarachnoid hemorrhage (SAH) and control patients with ICH or SAH who did not have COVID-19 admitted at the same hospitals in 2019. The analysis included 559 ICH-COVID-19 patients and 23,378 ICH controls from 194 hospitals and 212 SAH-COVID-19 patients and 5,029 SAH controls from 119 hospitals.<\/p>\n The researchers found that patients with ICH-COVID-19 had an adjusted odds ratio of 2.43 for death and an adjusted odds ratio of 0.55 for favorable discharge. In the SAH-COVID-19 cohort, the hospital (26.9 versus 13.4 days) and intensive care (21.9 versus 9.6 days) length of stays and in-hospital mortality rate (42.9 versus 14.8 percent) were higher compared with controls. Patients with SAH-COVID-19 had an adjusted odds ratio of 1.81 for death and an adjusted odds ratio of 0.54 for favorable discharge.<\/p>\n “This is one of the first studies to document that, in patients with hemorrhagic stroke who have comorbid COVID-19, there is a significantly elevated risk of in-hospital death,” a coauthor said in a statement. “This finding warrants additional study and potentially more aggressive treatment of either condition.”<\/p>\n Two authors disclosed an affiliation with Vizient.<\/p>\n